{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T15:31:16Z","timestamp":1775575876827,"version":"3.50.1"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["U19AI104209"],"award-info":[{"award-number":["U19AI104209"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AR067145"],"award-info":[{"award-number":["R01AR067145"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AI125567"],"award-info":[{"award-number":["R01AI125567"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.coi.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T01:58:51Z","timestamp":1504749531000},"page":"82-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Immune monitoring for precision medicine in allergy and asthma"],"prefix":"10.1016","volume":"48","author":[{"given":"Scott Dexter","family":"Boyd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona Amy","family":"Hoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5116-1942","authenticated-orcid":false,"given":"Kari Christine","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Joseph","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2017.08.007_bib0425","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(01)40417-X","article-title":"Further observations on the treatment of hay fever by hypodermic inoculations of pollen vaccine","volume":"178","author":"Freeman","year":"1911","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2017.08.007_bib0430","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0140-6736(01)56900-7","article-title":"Vaccination against hay fever: report of results during the last three years","volume":"183","author":"Freeman","year":"1914","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2017.08.007_bib0435","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/S0140-6736(00)78276-6","article-title":"Prophylactic inoculation against hay fever","volume":"177","author":"Noon","year":"1911","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2017.08.007_bib0440","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.jaci.2016.03.006","article-title":"Toward precision medicine and health: opportunities and challenges in allergic diseases","volume":"137","author":"Galli","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0445","series-title":"Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease","author":"Desmond-Helmann","year":"2011"},{"key":"10.1016\/j.coi.2017.08.007_bib0450","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.it.2013.04.003","article-title":"Food allergy: an enigmatic epidemic","volume":"34","author":"Berin","year":"2013","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0455","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.coi.2011.08.010","article-title":"Food allergy: mechanisms and therapeutics","volume":"23","author":"Berin","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0460","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jaci.2016.02.004","article-title":"Molecular and cellular mechanisms of food allergy and food tolerance","volume":"137","author":"Chinthrajah","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0465","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jaci.2016.02.010","article-title":"Advances and highlights in mechanisms of allergic disease in 2015","volume":"137","author":"Wawrzyniak","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0470","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nri.2016.111","article-title":"Food allergy: immune mechanisms, diagnosis and immunotherapy","volume":"16","author":"Yu","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0475","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/all.13132","article-title":"Precision medicine in allergic disease\u2014food allergy, drug allergy, and anaphylaxis\u2014PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma and Immunology","volume":"72","author":"Muraro","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2017.08.007_bib0480","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaci.2014.02.022","article-title":"Allergic sensitization is a key risk factor for but not synonymous with allergic disease","volume":"134","author":"Hamilton","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0485","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/0091-6749(88)90135-2","article-title":"Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual","volume":"82","author":"Bock","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0490","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/CCLM.2006.024","article-title":"Allergy testing: the role of recombinant allergens","volume":"44","author":"Mothes","year":"2006","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0495","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ymeth.2013.10.008","article-title":"Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip","volume":"66","author":"Lupinek","year":"2014","journal-title":"Methods"},{"key":"10.1016\/j.coi.2017.08.007_bib0500","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11882-012-0318-8","article-title":"Overview of component resolved diagnostics","volume":"13","author":"Treudler","year":"2013","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.coi.2017.08.007_bib0505","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11882-015-0534-0","article-title":"Utility of component-resolved diagnostics in food allergy","volume":"15","author":"Tuano","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.coi.2017.08.007_sbref0510","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11882-016-0633-6","article-title":"Pros and Cons of clinical basophil testing (BAT)","volume":"16","author":"Hoffmann","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.coi.2017.08.007_bib0515","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jaci.2014.04.039","article-title":"Basophil activation test discriminates between allergy and tolerance in peanut-sensitized children","volume":"134","author":"Santos","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.04.060","article-title":"Assessing basophil activation by using flow cytometry and mass cytometry in blood stored 24hours before analysis","volume":"139","author":"Mukai","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0525","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1126\/science.1198704","article-title":"Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum","volume":"332","author":"Bendall","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coi.2017.08.007_sbref0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.06.048","article-title":"Mass cytometry profiling the response of basophils and the complete peripheral blood compartment to peanut","volume":"138","author":"Tordesillas","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.03.030","article-title":"Direct monitoring of basophil degranulation by using avidin-based probes","author":"Joulia","year":"2017","journal-title":"J Allergy Clin Immunol."},{"key":"10.1016\/j.coi.2017.08.007_sbref0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.03.052","article-title":"A new fluorescent-avidin-based method for quantifying basophil activation in whole blood","author":"Mukai","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0545","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coi.2017.08.007_bib0550","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1183\/09031936.00100811","article-title":"Identification of asthma clusters in two independent Korean adult asthma cohorts","volume":"41","author":"Kim","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coi.2017.08.007_bib0555","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jaci.2010.11.037","article-title":"Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome","volume":"127","author":"Lotvall","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0560","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1183\/09031936.00105013","article-title":"Elevated expression of the NLRP3 inflammasome in neutrophilic asthma","volume":"43","author":"Simpson","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coi.2017.08.007_bib0565","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MCP.0000000000000225","article-title":"Asthma phenotypes and endotypes: a personalized approach to treatment","volume":"22","author":"Skloot","year":"2016","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0570","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1164\/ajrccm.160.3.9812110","article-title":"Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics","volume":"160","author":"Wenzel","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0575","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0580","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1056\/NEJM199501193320301","article-title":"Asthma and wheezing in the first six years of life. The Group Health Medical Associates","volume":"332","author":"Martinez","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0585","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1513\/pats.200607-144JG","article-title":"Gene\u2013environment interactions in asthma: with apologies to William of Ockham","volume":"4","author":"Martinez","year":"2007","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.coi.2017.08.007_bib0590","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jaci.2015.04.048","article-title":"Predicting asthma outcomes","volume":"136","author":"Sears","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0595","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11882-015-0529-x","article-title":"The complex type 2 endotype in allergy and asthma: from laboratory to bedside","volume":"15","author":"Agache","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.coi.2017.08.007_sbref0600","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.jaci.2016.03.010","article-title":"Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"137","author":"Muraro","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0605","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jaci.2016.03.009","article-title":"Biomarkers in asthmatic patients: has their time come to direct treatment?","volume":"137","author":"Berry","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0610","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaci.2016.03.012","article-title":"Immune biomarkers in the spectrum of childhood noncommunicable diseases","volume":"137","author":"Skevaki","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0615","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.alit.2015.04.012","article-title":"Recent developments regarding periostin in bronchial asthma","volume":"64 Suppl","author":"Izuhara","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.coi.2017.08.007_bib0620","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.alit.2014.07.003","article-title":"Phenotype of asthma related with high serum periostin levels","volume":"64","author":"Matsusaka","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.coi.2017.08.007_bib0625","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1517\/14712598.2015.1090972","article-title":"Update on reslizumab for eosinophilic asthma","volume":"15","author":"Cardet","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.coi.2017.08.007_bib0630","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1056\/NEJMoa1106469","article-title":"Lebrikizumab treatment in adults with asthma","volume":"365","author":"Corren","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0635","doi-asserted-by":"crossref","DOI":"10.1097\/ACI.0000000000000108","article-title":"Anti-interleukin 4 and 13 for asthma treatment in the era of endotypes","author":"Kau","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.03.051","article-title":"Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids","volume":"132","author":"Noonan","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0645","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jaci.2010.08.001","article-title":"IL-4 receptor alpha polymorphisms are predictors of a pharmacogenetic response to a novel IL-4\/IL-13 antagonist","volume":"126","author":"Slager","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0650","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(07)61600-6","article-title":"Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies","volume":"370","author":"Wenzel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2017.08.007_bib0655","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0660","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.alit.2015.04.001","article-title":"No increase in the serum periostin level is detected in elementary school-age children with allergic diseases","volume":"64","author":"Inoue","year":"2015","journal-title":"Allergol Int"},{"key":"10.1016\/j.coi.2017.08.007_bib0665","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/pai.12457","article-title":"Predicting asthma morbidity in children using proposed markers of Th2-type inflammation","volume":"26","author":"Konradsen","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0670","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1164\/rccm.201103-0396OC","article-title":"Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study","volume":"184","author":"Castro","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0675","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-2600(14)70201-2","article-title":"Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","volume":"2","author":"Castro","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0680","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0685","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1056\/NEJMoa0805435","article-title":"Mepolizumab for prednisone-dependent asthma with sputum eosinophilia","volume":"360","author":"Nair","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0690","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2013.05.007","article-title":"What is an \u201ceosinophilic phenotype\u201d of asthma?","volume":"132","author":"Nair","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0695","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/rccm.201601-0107OC","article-title":"Gene expression profiling in blood provides reproducible molecular insights into asthma control","volume":"195","author":"Croteau-Chonka","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0700","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1164\/rccm.201608-1600ED","article-title":"Toward precision medicine of symptom control in asthma","volume":"195","author":"Gomez","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coi.2017.08.007_sbref0705","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad2722","article-title":"A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases","volume":"7","author":"Gustafsson","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.07.029","article-title":"Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy","volume":"134","author":"Lao-Araya","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0715","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40413-016-0094-3","article-title":"Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases","volume":"9","author":"Metcalfe","year":"2016","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.coi.2017.08.007_sbref0720","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11882-017-0689-y","article-title":"Human immune monitoring techniques during food allergen immunotherapy","volume":"17","author":"Rust","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.coi.2017.08.007_sbref0725","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MCP.0000000000000335","article-title":"Pharmacogenetics of asthma: toward precision medicine","volume":"23","author":"Kersten","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.coi.2017.08.007_sbref0730","first-page":"9","article-title":"Asthma pharmacogenetics and the development of genetic profiles for personalized medicine","volume":"8","author":"Ortega","year":"2015","journal-title":"Pharmgenomics Pers Med"},{"key":"10.1016\/j.coi.2017.08.007_sbref0735","doi-asserted-by":"crossref","DOI":"10.1111\/all.13138","article-title":"Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper","author":"Shamji","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2017.08.007_sbref0740","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1613125","article-title":"KIT inhibition by imatinib in patients with severe refractory asthma","volume":"376","author":"Cahill","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0745","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1056\/NEJMe1702653","article-title":"Mast cells and KIT as potential therapeutic targets in severe asthma","volume":"376","author":"Galli","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0750","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-065X.2011.01029.x","article-title":"The genetics of asthma and allergic disease: a 21st century perspective","volume":"242","author":"Ober","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2017.08.007_bib0755","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/cea.12327","article-title":"Genetic risk factors for the development of allergic disease identified by genome-wide association","volume":"45","author":"Portelli","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coi.2017.08.007_bib0760","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nri2257","article-title":"Discovering susceptibility genes for asthma and allergy","volume":"8","author":"Vercelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0765","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1056\/NEJMoa1414850","article-title":"Randomized trial of peanut consumption in infants at risk for peanut allergy","volume":"372","author":"Du Toit","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0770","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11882-002-0041-y","article-title":"How much food is too much? Threshold doses for allergenic foods","volume":"2","author":"Hefle","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.coi.2017.08.007_bib0775","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40413-015-0081-0","article-title":"Risk multipliers for severe food anaphylaxis","volume":"8","author":"Smith","year":"2015","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.coi.2017.08.007_bib0780","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaci.2013.11.020","article-title":"Food allergy: epidemiology, pathogenesis, diagnosis, and treatment","volume":"133","author":"Sicherer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0785","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1126\/scitranslmed.aaa7390","article-title":"Advances in allergen immunotherapy: aiming for complete tolerance to allergens","volume":"7","author":"Akdis","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0790","doi-asserted-by":"crossref","first-page":"S306","DOI":"10.1016\/j.jaci.2009.10.064","article-title":"Allergen immunotherapy","volume":"125","author":"Frew","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0795","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri1934","article-title":"Immunological mechanisms of allergen-specific immunotherapy","volume":"6","author":"Larche","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0800","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1200435","article-title":"Oral immunotherapy for treatment of egg allergy in children","volume":"367","author":"Burks","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2017.08.007_bib0805","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jaci.2013.12.1037","article-title":"Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3)","volume":"133","author":"Syed","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_bib0810","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2013.11.007","article-title":"Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy","volume":"133","author":"Vickery","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0815","doi-asserted-by":"crossref","first-page":"E1286","DOI":"10.1073\/pnas.1520180113","article-title":"Successful immunotherapy induces previously unidentified allergen-specific CD4+ T-cell subsets","volume":"113","author":"Ryan","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2017.08.007_sbref0820","article-title":"Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells","author":"Schulten","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0825","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaci.2015.05.029","article-title":"Single B-cell deconvolution of peanut-specific antibody responses in allergic patients","volume":"137","author":"Hoh","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.03.026","article-title":"Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects","volume":"136","author":"Patil","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.09.049","article-title":"Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response","volume":"135","author":"Shamji","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2017.08.007_sbref0840","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/cea.12862","article-title":"Individually dosed omalizumab: an effective treatment for severe peanut allergy","volume":"47","author":"Brandstr\u00f6m","year":"2017","journal-title":"Clin Exp Allergy"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517300742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517300742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:43:23Z","timestamp":1760604203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791517300742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":84,"alternative-id":["S0952791517300742"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2017.08.007","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune monitoring for precision medicine in allergy and asthma","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}